Credit Capital Investments LLC Edwards Lifesciences Corp Transaction History

Credit Capital Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $388,799 - $524,048	5,612 New	5,612 $388,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $422,969 - $550,934	5,135 New	5,135 $424,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $181,650 - $269,367	-2,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $214,116 - $269,514	2,100 New	2,100 $247,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Credit Capital Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Credit Capital Investments LLC with notifications on news.